# Daptomycin Versus Placebo in Patients With Neutropenia and Fever

> **NCT01216241** · PHASE3 · TERMINATED · sponsor: **University of Rochester** · enrollment: 36 (actual)

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DRUG:** Daptomycin
- **OTHER:** Saline Placebo
- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT01216241
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** The study has shown futility and the objectives could not be reached without enrolling a very large number of subjects.
- **Last updated:** 2014-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01216241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01216241, "Daptomycin Versus Placebo in Patients With Neutropenia and Fever". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01216241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*